Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, today announced participation in one- ...

Nest’s design is philosophically inspired by Angular. At its heart is a dependency injection (DI) engine that wires together ...

The U.S. market for treating Type 1 diabetes was valued at $15.95 billion in 2024, according to a research report.

Bard’s most recent ride was in Cape Cod. He raised $6,000, contributing to Breakthrough T1D’s grand total of $2.1 million.

A cheap, century-old medication can improve life for people with type 1 diabetes, according to new research. A clinical trial ...

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction ...